Prevention of Ventilator-Associated Pneumonia with Inhaled Amikacin
A short course of inhaled amikacin at therapeutic doses prevented the occurrence of ventilator-associated pneumonia without changes to duration of mechanical ventilation, length of stay, or mortality.
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.